Home › NDC Lookup › RxCUI directory › RxCUI 1486165

Cysteine hydrochloride 50 MG/ML Injectable Solution — RxCUI 1486165

Name: Cysteine hydrochloride 50 MG/ML Injectable Solution (RxCUI 1486165)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 1486165 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1486165

Official nameCysteine hydrochloride 50 MG/ML Injectable Solution

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known ascysteine HCl 50 MG/ML Injectable Solution

FDA products mapped2

Package NDCs mapped2

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

🕸️ Concept Web — How Cysteine hydrochloride 50 MG/ML Injectable Solut... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Cysteine hydrochloride 50 MG/ML Injectable Solution RxCUI 1486165 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Cysteine 3024 IN
- Cysteine hydrochloride 221086 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Elcys 2169277 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Cysteine Injectable Solution 377094 SCDF
- Cysteine hydrochloride Injectable Solution 2645596 SCDFP
- Cysteine Injectable Product 1151475 SCDG
- Cysteine hydrochloride Injectable Product 2661304 SCDGP
- Cysteine Injectable Solution [Elcys] 2671583 SBDF
- Cysteine hydrochloride Injectable Solution [Elcys] 2671584 SBDFP
- Elcys Injectable Product 2169280 SBDG
- Injectable Solution 316949 DF
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Cysteine hydrochloride 50 MG/ML 1486161 SCDC
- Cysteine hydrochloride 50 MG/ML Injectable Solution [Elcys] 2671585 SBD
- Cysteine hydrochloride 50 MG/ML [Elcys] 2169278 SBDC

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Cysteine hydrochloride 50 MG/ML SCDC · 1486161
Cysteine Injectable Solution SCDF · 377094
Cysteine hydrochloride Injectable Solution SCDFP · 2645596
Cysteine Injectable Product SCDG · 1151475
Cysteine hydrochloride Injectable Product SCDGP · 2661304

Brand-Name Concepts

Cysteine hydrochloride 50 MG/ML Injectable Solution [Elcys] SBD · 2671585
Cysteine hydrochloride 50 MG/ML [Elcys] SBDC · 2169278
Cysteine Injectable Solution [Elcys] SBDF · 2671583
Cysteine hydrochloride Injectable Solution [Elcys] SBDFP · 2671584
Elcys Injectable Product SBDG · 2169280
Elcys BN · 2169277

📦 FDA Products & Package NDCs

2 products · 2 package NDCs

2 package NDCs map to RxCUI 1486165 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
51754-1008-01	1 VIAL in 1 CARTON (51754-1008-1) / 50 mL in 1 VIAL	ELCYS	Exela Pharma Sciences, LLC	2024-01-01
51754-1008-04	25 VIAL in 1 CARTON (51754-1008-4) / 50 mL in 1 VIAL	ELCYS	Exela Pharma Sciences, LLC	2024-01-01

Observed labelers: Exela Pharma Sciences, LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.